Our findings demonstrate that TNFα inhibitor thalidomide markedly diminishes the severity of experimental HPS and muscle wasting by down-regulation of common peripheral and local NFκB-iNOS pathway. The gene discussed is TNF; the disease is Hermansky-Pudlak syndrome.